Login

Abbott India Ltd.

₹30795.0

Overview Charts Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Corp. Action Documents
Consolidated
Standalone

Abbott India Ltd.

₹30795.0

₹30795.0

-350.0 (-1.12%) - 24 May 2025 03:37 PM

About Company

Abbott India Limited, a publicly listed company and a subsidiary of Abbott Laboratories, offers high-quality trusted medicines in multiple therapeutic categories such as women’s health, gastroenterology, cardiology, metabolic disorders and primary care. It is one of India's fastest-growing pharmaceutical companies. It has expertise across product development, manufacturing, sales and customer service and are dedicated to providing high-quality, reliable products with the expert clinical support its customers need. The company’s in-house development and medical teams undertake product and clinical development tailored to the unique needs of the Indian market.

Market Cap. ₹ 65,437 Cr.
52 Week - High/Low ₹ 31,899/25,325
P/E Ratio 46.27
P/B Ratio 17.69
Enterprise Value ₹ -1,998 Cr.
ROE % 35.31
RSI Value 54.40
EMA 50 30202.43
EMA 200 28960.67
Market Cap. ₹ 65,437 Cr.
52 Week - High/Low ₹ 31,899/25,325
P/E Ratio N/A
P/B Ratio N/A
Enterprise Value -
ROE % 37.45
RSI Value 54.40
EMA 50 30202.43
EMA 200 28960.67
Add Parameters

Growth

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Terms | Privacy | Contact Us
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.